Organization
Kelonia Therapeutics
6 articles
No recent mentions
Eli Lilly to Acquire Kelonia Therapeutics for $3.25 Billion to Boost Oncology Portfolio
Eli Lilly announced its acquisition of Kelonia Therapeutics for over $3 billion, aiming to strengthen its oncology and CAR-T therapy portfolio. This strategic move reflects Lilly's focus on expanding its presence in cancer treatment and genetic medicines.
· 42d ago
Eli Lilly Acquires Kelonia for $3.25 Billion to Strengthen Cancer and Autoimmune Treatment R&D
Eli Lilly is acquiring Kelonia Therapeutics for $3.25 billion, aiming to advance cell therapies for cancer and autoimmune diseases. The deal underscores Lilly's strategy to lead in innovative biotech and cancer treatment development.
· 46d ago